Also known as: 1-aminoadamantane Amantadine Amantadine hydrochloride
Amantadine is indicated for:
Population group: both men and women, only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)
Amantadine is indicated in patients suffering from clinical influenza in which complications might be expected to occur.
Additionally, amantadine is recommended prophylactically in cases particularly at risk, including:
Amantadine does not completely prevent the host immune response to influenza A infection, so individuals who take this drug still develop immune responses to the natural disease or vaccination and may be protected when later exposed to antigenically related viruses.
Amantadine is also indicated in post-exposure prophylaxis in conjunction with inactivated vaccine during an outbreak until protective antibodies develop, or in patients who are not expected to have a substantial antibody response (immunosuppression).
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: both men and women, only adults (18 years old or older)
Amantadine is indicated for Parkinson’s disease.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: both men and women, only adults (18 years old or older)
Amantadine is indicated for Herpes zoster. Amantadine in elderly or debilitated patients in whom the physician suspects that a severe and painful rash could occur. Amantadine can significantly reduce the proportion of patients experiencing pain of long duration.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Amantadine is contraindicated in the following cases: